Alkem Laboratories (ALKEM) | Stock Overview & Key Data
Alkem Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹5,425.00
High: ₹5,519.00
on October 3, 2025
52 Week Range
Low: ₹4,491.65
High: ₹6,375.55
on February 28, 2025
on October 9, 2024
All-Time High: ₹6,439.90 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR661.8B
EPS
191.24
P/E Ratio (TTM)
28.55
Forward P/E
25.52
P/B Ratio
5.45
PEG Ratio
1.31
Div. Yield
0.87%
ROE
17.42%
Beta
0.344
Debt to Equity
11.11
Financial Highlights
Profitability
Gross Margin
65.26%
Operating Margin
19.32%
Profit Margin
17.17%
Returns and Earnings
Return on Assets (TTM)
12.24%
Return on Equity (TTM)
17.42%
EBITDA
INR30.7B
Net Income (TTM)
INR22.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR1,112.69
Quarterly Revenue Growth (YoY)
11.20%
Quarterly Earnings Growth (YoY)
21.80%
Dividend Information
Last 12-Month Dividend
₹42.00
Current Dividend Yield
0.87%
3-Year Average Dividend Yield
0.45%
3-Year Average Annual Dividend
₹38.67
3-Year Total Dividends
₹116.00
Ex-Dividend Date
February 14, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Alkem Laboratories ALKEM | 661.78B Large-cap | 0.17% | 2.83% | 12.86% | 9.46% | -2.32% | -12.14% | 70.05% | 99.79% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 2.80% | 3.33% | -2.89% | -7.84% | -13.69% | -14.60% | 70.78% | 218.03% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | 3.10% | -4.83% | -14.69% | 1.79% | -3.41% | 8.12% | 57.02% | 83.89% |
| Torrent TORNTPHARM | 1.24T Large-cap | -1.30% | -2.55% | 5.42% | 8.22% | 2.81% | 1.18% | 123.52% | 25.54% |
| Cipla CIPLA | 1.22T Large-cap | 1.22% | -3.85% | 0.60% | 1.47% | 2.59% | 5.43% | 34.25% | 88.97% |
| Dr. Reddy's DRREDDY | 1.05T Large-cap | -0.40% | -1.12% | -3.35% | 8.39% | -8.83% | -5.92% | 42.59% | 21.10% |
Ownership & Short Interest
Insider Ownership
65.10%
Institutional Ownership
23.25%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
223K
Average 90-Day Volume
159K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALKEM's 52-week high and low?
- In the last 52 weeks, Alkem Laboratories reached a high of ₹6,375.55 (on October 9, 2024) and a low of ₹4,491.65 (on February 28, 2025).
- What is the market cap and P/E ratio for ALKEM?
- Curious about Alkem Laboratories's size and valuation? Its market capitalization stands at 661.78B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.55, and the forward P/E (looking ahead) is 25.52.
- Does ALKEM pay dividends? If so, what's the yield?
- Yes, Alkem Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.87%, and the company has paid an average of ₹38.67 per share annually over the past 3 years.
- Who are Alkem Laboratories's main competitors or similar companies to consider before investing?
When looking at Alkem Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -14.60% 70.78% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 8.12% 57.02% Torrent
TORNTPHARM1.24T Healthcare Drug Manufacturers - Specialty & Generic 1.18% 123.52% Cipla
CIPLA1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.43% 34.25% Dr. Reddy's
DRREDDY1.05T Healthcare Drug Manufacturers - Specialty & Generic -5.92% 42.59% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Alkem Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Alkem Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.42%, the Debt to Equity ratio from the most recent quarter is 11.11, and its Gross Profit Margin stands at 65.26%.
- What is the recent revenue and earnings growth for ALKEM?
- Looking at Alkem Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR133B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.20%, and quarterly earnings saw a YoY growth of 21.80%.
- How much of ALKEM stock is held by insiders and institutions?
- Wondering who owns Alkem Laboratories stock? Company insiders (like executives and directors) hold about 65.10% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 23.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.